Results 91 to 100 of about 5,418,578 (179)

Twelve-year Experience for Tenosynovial Giant Cell Tumors of Tendon Sheath: A Review of 95 Cases from A Single Institution

open access: yesBagcilar Medical Bulletin
Objective: We aimed to present our 12-year experiences for tenosynovial giant cell tumors (TGCTs) of tendon sheath by summarizing the demographic characteristics and clinicopathological features of 95 cases who underwent excision of localized TGCT in a ...
Muhammed Uslu   +3 more
doaj   +1 more source

Imaging Findings of Pediatric Rheumatic Disorders: JIA in the PRINTO Era and Autoimmune Interferonopathies

open access: yesPediatrics International, Volume 68, Issue 1, January/December 2026.
ABSTRACT Treatment strategies for pediatric rheumatic diseases have changed substantially over the past two decades, driven by the development of biologics and cytokine‐targeted molecular therapy. Therapeutic approaches that modulate both innate and adaptive immune responses have improved prognosis in these immune‐mediated disorders, and early ...
Yuko Tsujioka   +4 more
wiley   +1 more source

Tenosynovial Giant Cell Tumor: Case Report and Review [PDF]

open access: yesArchives of Pathology & Laboratory Medicine, 2012
Tenosynovial giant cell tumors are a group of generally benign intra-articular and soft tissue tumors with common histologic features. They can be roughly divided into localized and diffuse types. Localized types include giant cell tumors of tendon sheath and localized pigmented villonodular synovitis, whereas diffuse types encompass conventional ...
openaire   +2 more sources

Tenosynovial giant cell tumor of hand: A rare case report

open access: yes
Giant cell tumor happens to be the second most common tumor of the hand.Being recently named as Tenosynovial Giant Cell Tumor, the localised type occurs predominantly in digits. We report a case of 23 year old female with progressive swelling in the hand
Dr Ramniwas Bishnoi   +3 more
core   +1 more source

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Tenosynovial giant cell tumours [PDF]

open access: yes, 2018
Tenosynoviale reusceltumoren (tenosynovial giant cell tumours, TGCT) zijn zeldzame goedaardige tumoren. Deze aandoening werd voorheen pigmented villonodular synovitis (PVNS) genoemd.
Mastboom, M.J.L.
core  

Chondroid Tenosynovial Giant Cell Tumor of the Temporomandibular Joint: A Rare Case Report [PDF]

open access: yes, 2017
Tenosynovial giant cell tumor of diffuse type (TGCT-d) or pigmented villonodular synovitis (PVNS) is a locally aggressive lesion that mostly affects the joints of long bones.
Oslei Paes de Almeida   +15 more
core   +1 more source

Unravelling the Mystery and Taming the Giant - A Case of Tenosynovial Giant Cell Tumor

open access: yes
INTRODUCTION: Tenosynovial giant cell tumors are classified into subtypes by growth pattern - localized-type vs diffuse-type and location - intra-articular vs extra-articular, they have a wide clinical spectrum effecting patients of all ages. CASE REPORT:
Dr. Shashikala v, Dr. Yanamadala Tejaswi
core   +1 more source

Open posterior synovectomy for treatment of tenosynovial giant cell tumors of the knee

open access: yesJournal of the Bulgarian Orthopaedics and Trauma Association
Objective:  Retrospective analysis of results from open posterior synovectomy for TGCT of knee joint Material and method:     The surgery technique includes an approach to retrocondylar space with retraction of m.
Kircho Patrikov   +4 more
doaj   +1 more source

Tenosynovial giant cell tumor of the ankle: a clinical case

open access: yesActa Biomedica Scientifica
Background. Tenosynovial giant cell tumor is a rare benign disease that primarily affects the synovium and tendon sheath. Its prevalence is 30.3 cases per million people per year.
I. A. Kuklin   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy